Chinese drug iza-bren doubles lung cancer survival window in phase 3 trial
An anticancer drug developed by Sichuan Biokin Pharmaceutical took centre stage in a late-breaking oral presentation at the European Society for Medical Oncology (ESMO) Congress in Madrid last week. Researchers said the drug, iza-bren,...
Lean: Leans right
Fact-focusedFactuality: HighCountry: Hong KongFunding: CorporateOwner: Alibaba Group
Coverage breakdown
Funding
Corporate
Countries
Hong Kong
Media ownership
Alibaba Group
Avg reliability75
Low-credibility share0%
Fact / opinion1/0
State media0%
More analysis
Truth score: 41 (Limited corroboration)
Propaganda risk: 0
Trending: Low
Sources: 1
Reliability: 75
Bias severity: 0
Risk: 0Sentiment: 0Sensationalism: 0
Amplification: 0